Treating TED: More Than Meets the Eye (CE Monograph)

Activity Description and Purpose

This educational activity aims to equip optometrists with advanced knowledge of the diagnosis, individualized treatment planning, and management of thyroid eye disease (TED), highlighting the importance of a collaborative, multidisciplinary care team. Through engaging content delivered by esteemed experts, participants will explore TED diagnostic criteria, the latest clinical data for creating personalized treatment plans, and effective strategies for managing adverse effects such as hyperglycemia and hearing loss associated with insulin-like growth factor-1 receptor antagonists. The educational activity integrates didactics, clinical case studies, and discussion panels, designed to reinforce learning objectives and encourage the application of knowledge in clinical settings. The desired results of this activity are to improve clinicians’ ability to accurately diagnose TED, optimally integrate therapies for TED according to clinical data, identify and manage treatment-related adverse events, and incorporate strategies for fostering multidisciplinary collaboration to ensure the best possible outcomes for patients living with this disease.

Target Audience

This educational activity is intended for optometrists.

Learning Objectives

After completing this activity, participants will be better able to:

  • Review diagnostic criteria that are critical in identifying patients with thyroid eye disease
  • Create individualized treatment plans for patients with thyroid eye disease according to the latest clinical data
  • Develop strategies for mitigating hyperglycemia and hearing loss in patients with thyroid eye disease receiving insulin-like growth factor 1 receptor antagonists
  • Outline the roles and responsibilities of the multidisciplinary care team in thyroid eye disease management
Course summary
Available credit: 
  • 1.50 COPE
Course opens: 
Course expires: 


Andrew G. Lee, MD (Chair)
Herb and Jean Lyman Centennial Chair in Ophthalmology
Department of Ophthalmology
Blanton Eye Institute
Professor of Ophthalmology, Neurology, and Neurosurgery
Academic Institute
Full Clinical Member
Research Institute
Houston Methodist
Weill Cornell Medical College
Houston, Texas
Eugene L. Alford, MD, FACS
Associate Professor of Otolaryngology and Plastic Surgery
Academic Institute Houston Methodist Hospital
Weill Medical College of Cornell University
Adjunct Professor
Texas A&M Intercollegiate College of Medicine (EnMed)
Houston, Texas
Victor J. Bernet, MD, FACE, FACP
Endocrinology, Diabetes and Metabolism Fellowship Program
Professor of Medicine
Mayo Clinic College of Medicine and Science
Mayo Clinic
Jacksonville, Florida
Wendy W. Lee, MD, MS
Professor of Clinical Ophthalmology and Dermatology
Oculofacial Plastic & Reconstructive Surgery, Orbit, and Oncology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, Florida
Joseph Sowka, OD, FAAO
Center for Sight
Venice, Florida
Prem S. Subramanian, MD, PhD
Chief, Neuro-Ophthalmology
Clifford R. and Janice N. Merrill Endowed Chair in Ophthalmology
Vice Chair for Academic Affairs, Ophthalmology
Professor in Ophthalmology, Neurology, and Neurosurgery
Sue Anschutz-Rodgers University of Colorado Eye Center
University of Colorado School of Medicine
Aurora, Colorado

Disclosure Policy

MedEdicus requires that anyone who is in a position to control the content of this educational activity disclose all relevant financial relationships with any commercial interest. Financial relationship information is collected and resolved prior to the educational activity. All relevant relationships have been mitigated.


Eugene Alford, MD, has no relevant commercial relationships to disclose.

Victor Bernet, MD, has no relevant commercial relationships to disclose.

Andrew G. Lee, MD, is a consultant for Alexion Pharmaceuticals, Inc, AstraZeneca, Bristol-Myers Squibb, Stoke Therapeutics and Viridian Therapeutics, Inc; and is on the speakers bureau for Amgen Inc.

Wendy W. Lee, MD, MS, is a consultant for AbbVie Inc, Amgen Inc, Mallinckrodt*,  Novabay Pharmaceuticals, Inc, Revance Therapeutics, Inc, RVL Pharmaceuticals, Inc*, and Tarsus Pharmaceuticals, Inc; and is a contracted researcher for Viridian Therapeutics, Inc.

Joseph Sowka, OD, is on the speakers bureau for Bausch & Lomb Incorporated.

Prem S. Subramanian, MD, PhD, is a consultant for ACELYRIN, Inc; is an advisory board member of Amgen Inc, GenSight Biologics, Kriya Therapeutics, and Viridian Therapeutics, Inc; and is a contracted researcher for Amgen Inc, Immunovant, Inc, Invex Therapeutics*, Neurophth Therapeutics, Tourmaline Bio, Inc, and Viridian Therapeutics, Inc.

Peer Reviewer

Hadi Kaakour, MD, was formerly an advisory board member of Alimera Sciences*.

Planners, Managers, and Writers

MedEdicus planners, managers, and writers have no relevant commercial relationships to disclose.

* The financial relationship existed during the past 24 months but has now ended.

Accreditation Statement

 COPE approved for 1.5 CE credits for optometrists. 
COPE course ID: 91124-SD (Asynchronous)
COPE Course Category: Systemic Disease


This activity, COPE Activity Number 128309, is accredited by COPE for continuing education for optometrists.

Disclosure of Commercial Support

MedEdicus has received commercial support from Amgen Inc for this activity in the form of an unrestricted educational grant.

The content of this COPE-accredited CE activity was planned and prepared independently by MedEdicus without input from members of an ineligible company.

Off-Label Discussion

This educational activity may include discussion of unlabeled and/or investigational uses of drugs or devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.

Sponsored by 

Provider Contact Information

For questions about this educational activity, please contact MedEdicus LLC at


The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the State University of New York College of Optometry, MedEdicus LLC, or Amgen Inc.

This CE activity is copyrighted to MedEdicus LLC ©2024. All rights reserved. MedEdicus does not claim copyright to material included herein owned by third parties for which attribution or citation has been made. 313

Available Credit

  • 1.50 COPE
Please login or register to take this course.

Clicking Register/Take course indicates that you have reviewed the CE information for this activity.